Cover Image

The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study

There is a lack of studies investigating the clinical benefits of prebiotic-supplemented infant formula. In this study, healthy infants that started, on medical recommendation, artificial feeding with one of 2 infant formulas containing 4 g/L of GOS/FOS (9:1) (IF4 group; n = 60) or 8 g/L of GOS/FOS...

Full description

Saved in:
Bibliographic Details
Main Authors: Karina Merini Tonon PhD (Author), Thaís Moreno Tomé BSND (Author), Elaine Martins Bento Mosquera (Author), Natália Pratis Perina PhD (Author), Tamara Lazarini MSc (Author)
Format: Book
Published: SAGE Publishing, 2021-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4df4de2bcc724fc6be9990db4b0912c0
042 |a dc 
100 1 0 |a Karina Merini Tonon PhD  |e author 
700 1 0 |a Thaís Moreno Tomé BSND  |e author 
700 1 0 |a Elaine Martins Bento Mosquera  |e author 
700 1 0 |a Natália Pratis Perina PhD  |e author 
700 1 0 |a Tamara Lazarini MSc  |e author 
245 0 0 |a The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study 
260 |b SAGE Publishing,   |c 2021-09-01T00:00:00Z. 
500 |a 2333-794X 
500 |a 10.1177/2333794X211044115 
520 |a There is a lack of studies investigating the clinical benefits of prebiotic-supplemented infant formula. In this study, healthy infants that started, on medical recommendation, artificial feeding with one of 2 infant formulas containing 4 g/L of GOS/FOS (9:1) (IF4 group; n = 60) or 8 g/L of GOS/FOS (9:1) (IF8 group; n = 60) were followed for 30 days to the evaluation of growth and gastrointestinal symptoms. Exclusively breastfed infants (EBF; n = 60) were followed up as a reference. Both infant formulas supported adequate weight gain, however, IF4 formula promotes growth more similar to breastfed infants. There was no additional benefit of a dose higher than 4 g/L of GOS/FOS on gastrointestinal symptoms. 
546 |a EN 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Global Pediatric Health, Vol 8 (2021) 
787 0 |n https://doi.org/10.1177/2333794X211044115 
787 0 |n https://doaj.org/toc/2333-794X 
856 4 1 |u https://doaj.org/article/4df4de2bcc724fc6be9990db4b0912c0  |z Connect to this object online. 

Similar Items